Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. It offers generic drugs, active pharmaceutical ingredients, and over the counter drugs; and contract manufacturing services for formulations products, high-potent drugs, and packaging. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
Stock data | 2023 | Change |
---|---|---|
Price | $15.66 | N/A |
Market Cap | $247.66M | N/A |
Shares Outstanding | 15.81M | 3.30% |
Employees | 1.01K | N/A |
Shareholder Equity | 50.97B | 6.92% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.07 | N/A |
P/S Ratio | 0.78 | N/A |
P/B Ratio | 0.00 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0005 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $316.15M | N/A |
Earnings | $24.72M | N/A |
EPS | 227.43 | N/A |
Earnings Yield | 14.52 | N/A |
Gross Margin | 0.2291 | N/A |
Operating Margin | 0.1155 | N/A |
Net income margin | 0.0782 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $494.55M | N/A |
Total Debt | $34.76M | N/A |
Cash on Hand | $25.28M | N/A |
Debt to Equity | 0.0027 | 6.05% |
Cash to Debt | 0.7275 | -42.76% |
Current Ratio | $2.64 | -2.18% |